Qing Xi Ooi supports clients with hands-on analysis and strategic advice

Viviana Moroso brings scientific depth to quality control

Siv Jönsson develops Pharmetheus’s learning agenda
Events
News

Contact us

Home
About us
People
Sophie Peigné

Sophie Peigné

Sophie Peigné, Ph.D.

Senior Director, MIDD Consultant

Google scholar

Joined Pharmetheus in 2022, actively working in client projects
Expertise includes clinical pharmacokinetics, pediatric drug development, in-vitro in-vivo correlation, and pharmacometrics in therapeutic areas such as oncology, immuno-oncology, cardiology, and neurology
Previously worked as PK Project Manager and Principal Pharmacometrician at Servier, France
Pharm.D. (2010), Master Degree in Pharmacokinetics (2010), and Ph.D. in Pharmacometrics (2015) from the University of Paris V, France

Pharmetheus affiliated publications

Population Pharmacokinetic Analysis of Datopotamab Deruxtecan (Dato-DXd), a TROP2-Directed Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors Exposure-efficacy analysis of datopotamab deruxtecan (Dato-DXd), a TROP2-directed antibody-drug conjugate, in patients with advanced non-small cell lung cancer Population pharmacokinetic analysis of Datopotamab deruxtecan (Dato-DXd), a TROP2-targeting antibody-drug conjugate

Contact

Pharmetheus AB
Kungsängstull 4  
753 19 Uppsala, Sweden

Visiting address:  
Dragarbrunnsgatan 77, 5th floor

LinkedIn
YouTube

Science & Services
Quick links

About Pharmetheus

Pharmetheus is a consultancy firm helping clients reduce uncertainty in technical and regulatory processes, increasing confidence in the development of new medicines that can improve patients’ lives.

Whistleblower
Privacy Policy
Cookie Policy